Haider is an entrepreneur, blending innovation, commercial and marketing leadership into brands. He is specialised on business transformation and product launches within regulated industries such as pharma. Haider Alleg was most recently Global Head of Digital Excellence for Ferring Pharmaceuticals and is now General Partner at Allegory Capital.
Developing a natural obsession for creating new customer experiences, Haider disrupts the way global organisations adopt new marketing and technology trends. He is inspired by Japanese methodologies (Kaizen and Lean 6 Sigma) and adapts them to commercial operations to scale their business models globally.
Entrepreneur, he founded his first company at 16 in the East of France, specialised in political campaigns and social media. In 2013 he founded one of the fastest-growing consulting and venture firms in Switzerland, supporting companies like PregLem SA, sold to Gedeon Richter for 500M€. In 2015, he founded the Swiss hub of the French Tech initiative, created by the French President Emmanuel Macron.
Feel free to follow him on his Twitter account (@Haider_Alleg).
Antoine has been involved with Startups as a coach, consultant, trainer, investor, advisor on fundraising for over 10 years, with a fair degree of success as measured by their progress. Before that, he had accumulated a rare experience as a global investor in Equities and Private Equity with Capital Group, one of the best firms in the business, continuously visiting companies around the world in a high-paced environment. As a result he has a great flair for business models of all kinds and in all geographies, for management teams, their potential to create value – and thus can help you best understand investors' expectations, and how to pitch to them.
He is at his best helping companies, in a challenging but friendly and constructive style, to best align their project with their core skills, chose which markets to focus on and why, fine-tune their product strategy, develop a solid financial model. Aside from work, Antoine is a keen long-distance open water swimmer, an enthusiastic mountaineer, a solid amateur singer, and a writer.
Sharon Brunt is a purpose-driven creative strategist, and passionate advocate for social and environmental change. During Sharon’s three decades of experience in brand, communications and innovation, she's worked on some of the world’s most famous brands, with some of the world’s largest companies including; Boots Healthcare, GSK, Reckitt Benckiser and Unilever—as well as indie brands, and startups. Sharon has been a mentor for Station F and is also a knowledge hub expert for Women of Wearables. Recent healthcare clients include Danone, Forth and Perrigo.
Anna Butterworth is a FemTech pioneer. She has been at the epicentre of the industry for over six years - before the term was even coined. Starting her career in PR she quickly found her calling in wider creative campaign strategy and moved through cause led organisations that support marginalised communities and promote their voices.
Landing at Elvie in 2015 she was the first communications hire and quickly grew the brand across 60+ territories leading the way in FemTech marketing strategy. Since branching out to create the world's first FemTech focused creative agency Ultra Violet, she has worked with global disruptors such as Thinx, Become, Doppel, Wuka, Mooncup, Womanizer, Soho House, The Eve Appeal and more.
Forging new paths and being the very first on the scene is in the fabric of Anna’s being. Not one to settle for the status quo, she consistently breaks barriers to test the waters for the latest innovation or venture. From securing the first live televised feature from a woman’s vagina (ITV This Morning), producing the very first inclusive sex chat show Private Parts (Venus Libido X WowTech) or curating the first above the line ad campaign on Oxford Street for period pants (Thinx launch in Selfidges), Anna is never afraid of pushing the industry forward, whatever it takes.
The latest venture brings future forecasting to the industry in a way that has never been done before.
Startup coach by vocation, accredited by 7 organizations of the entrepreneurial ecosystem, Caroline is also an entrepreneur & illustrator.
She helps you achieve your goals & exceed them if you wish, by revealing & enhancing skills for your projects, using her extended experience in the fields she has practical experience in, notably ICT & digital & data, as well as specific tools & her network.
Startups appreciate her involvement as a sparring partner, pragmatic approach and capacity to inspire them & develop their projects & skills. Some examples of topics achieved for early stage startups: consolidate who you target, your revenue model, setup your financials, enhance your pitch & pitching skills, next steps in the entrepreneurial ecosystem.
Feel free to discover amazing personalities coached overs 6 months (50+) and their recommendations on: https://ideix.io/startups/.
Jennifer Cubino brings many years of experience as a clinical research industry executive, most recently at IQVIA / Quintiles. She has a diverse background including creating and leading strategic partnerships, clinical trial operations, business strategy, precision medicine, technology development, and oncology. Her focus is developing high performing and engaged teams capable of tackling rapidly changing markets. With seven years of experience as a former IRB member at Tufts Medical Center, Jennifer has a deep commitment to patient well-being.
Jennifer has numerous posters and publications on the topic of integrating NGS into clinical research and has presented at international conferences on enhancing Executive Leadership skills.
Jennifer holds a Bachelor of Science from Cornell University, College of Agriculture and Life Sciences and a Master of Arts in Clinical Research from Boston University, College of Medicine. She is a certified LSS Green Belt and Certified Clinical Research Associate.
Frederik received his Master degree in Bioscience Engineering at the University of Ghent in Belgium. He focused on applying & evolving software architecture and patterns in the field of bio- and lab-informatics during the past 20 years.
In 2010, he was appointed as the new CEO of Genohm where he co-developed and commercialized SLIMS, a sample management, electronic lab notebook and lab digitizing solution for research labs in life sciences, biotechnology and university hospitals, up until 2018 when Genohm was acquired by Agilent Technologies.
Frederik is currently Associate VP & SLIMS GM at Agilent Technologies and holds a Board position at Alithea Genomics.
Eric Dy, PhD is co-founder and CEO of Bloomlife, a women’s health company designing remote prenatal care solutions to improve the health of women and babies.
Eric brings unique perspective on the opportunities and challenges in emerging healthcare technologies and delivery models informed by multidisciplinary technical expertise leading business development for Europe’s leading R&D institute, imec.
Eric earned his BSc in Bioengineering from Cornell and his MSc and PhD in Biomedical Engineering from UCLA.
Bloomlife has been recognized for their pioneering work winning Fast Company World Changing Ideas, Johnson & Johnson Quickfire Challenge, Richard Branson’s Extreme Tech Challenge, MedTech Innovator Award, and speaking at the White House Precision Public Health Summit.
Expertise: fundraising, marketing, product strategy, clinical studies, regulatory, HR...
Marta is a business development and marketing strategist with track record in Biotech and Medical Devices with leading multinationals and young innovators.
Following a career in marketing and commercial operations with Merck-Serono and then Medtronic, Marta has worked in woman’s health, ophthalmology, headache, hypertension, heart failure, orthobiologics, GI disease, neuropathic pain, biomarkers, digital health and the active implantables space.
Marta has extensive experience working with young innovators to bring their technologies to market. She is member of the Program Management Committee of the School for Biomedical Entrepreneurship (SITEM) of the University of Bern. where she teaches Innovation and medical marketing and sales. She also serves as Western Switzerland Liaison for the Swiss Biotech Association and is a trainer with Innosuisse at the EPFL Innovation Park.
Emi is an entrepreneur, running-enthusiast, investor and world traveler based in Boston. Prior to Joyance, she founded a diabetes digital health company, worked for Half Court Ventures, an early-stage VC firm, and was the Director for Harvard’s premier undergraduate competition, i3 Innovation Challenge. She holds a BA in Molecular Biology from Harvard College and is a co-author in two publications related to cardiovascular regeneration in Circulation Research and Nature Communications. At Joyance, she focuses on biotech and healthcare investments. Emi is passionate about health equity and helping founders accomplish their goals.
Nanci Govinder is a business angel investor, board member, executive coach, entrepreneurship trainer and a strategic advisor to startups and accelerators. She has worked for more than 20 years in medical device companies (Johnson & Johnson; Medtronic) as Senior Research Scientisit, Director of Marketing and Business Unit Manager. She then transitioned to startups as CEO for two companies and as a board member and investor. She was also the Head Coach for the Swiss Federal Innovation Promotion Agency, managing 20 business coaches and evaluating and supporting > 100 deep tech startup companies. She is a highly experienced business angel investor with a portfolio of >25 companies and two exits and was the Deal Leader, Switzerland, for Rising Tide Europe, a group of 270 women business angels across Europe.
Nanci also founded a local branch of the Healthcare Businesswomen’s Association (HBA), an international organization developing and promoting female thought leaders in the healthcare industry. She was a member of the European Board and a mentor.
Nanci has a B.Sc. degree in Chemistry and Applied Chemistry; a B.Sc. degree from the American Institute of Holistic Theology; an MBA; and a diploma in Corporate and Business Coaching.
Doug tries to help innovators deliver on their ideas through connecting them to knowledge, challenge and questions, structure and supporters. He most recently worked to develop and run the DayOne Accelerator for Digital Health solutions based in Basel. Doug helped to co-found the DayOne initiative for Healthcare Innovation that brings together healthcare innovators from Healthcare Providers, Pharma, Academia and startups.
Prior to this he had a career advising companies and start-ups in healthcare, financial services, engineering and media. He spent five years in a Fintech start-up and has also worked in Drug Development with a big Pharma company. He grew up in Australia and has worked in Australia, the United Kingdom, Sweden and Switzerland.
Reto has been is Business Coach at EPFL Innovation Park for the last14 years and is coaching many companies in the lifescience, BioTech, MedTech, B2B fields. He knows what it means to lead a start-up as he was Chairman of DistalMotion for 5+ years and he can pass on his experience on the following topics: business plans, sales & marketing, industrial partnerships, business and product development.
Educated at the University of Massachusetts Amherst, USA.
Until end of September 2022 Susan headed Strategic Excellence, for Merck Healthcare, with overall accountability for Strategy Development and Strategic Planning, Global Strategic Insights (Forecasting, Market Research and Business Intelligence) and Decision Sciences. Her focus was on architecting the Healthcare strategy for Merck, project and portfolio decision making, leading the strategy realisation office and overseeing business-critical strategic alliances.
Prior to that she served for several years as the Head of Global Business Development and Alliance Management and member of the executive board within the Biopharma business of Merck responsible for all partnering activities, taking the global lead role for identifying and executing Global Business Development opportunities for Merck Biopharma's R&D, and also the commercial portfolio plus Alliance Management closing the alliance with Pfizer on PDL-1, at the time the single biggest licensing transaction for a clinical stage asset for any company globally.
She has experience across the pharma and medical diagnostics industries previously working in R&D, regulatory affairs and manufacturing operations. Thirty years later it is time for Sue to write the next chapter of her life taking up a new challenge as Lifescience advisor for, as yet to be disclosed, operations.
Claude Joris, Secretary General of the world‘s most diversified and dynamic Life Science Cluster « BioAlps » is responsiblefor the promotion of the excellence and the performance of all life sciencesactors from Western Switzerland locally, nationwide and in the internationalarena.
He has an extensive experience in R&D, marketing, sales customer services andgeneral management. He gained those experiences in Switzerland but also as an expatliving in 8 different countries located in North America, Europe and Asia. Hedeveloped sales and marketing business activities and travelled in 82 countries.He contributed to the development and the growth of 7 swiss innovative tech start-upsusing his managerial and scientific competencies.
He worked for blue-chip companies: Capital Investment Ventures in Europe andUSA, Schlumberger, GoodYear Aircraft Engineering, Hach Ultra Analytics, Tornos,Usines Metallurgies de Vallorbe and small Startups.
His professional experiences cover a large spectrum of industrial and R&Ddomains: aerospace, oil and gas, investments, semi-conductor, pharmaceutical,biotech, medtech, healthcare, chemical, food, nuclear and fossil fuel power plants,water treatment plant, beverage, automotive, FMCG and scientific researchprojects.
He holds two university master degrees in civil engineering (PolytechnicUniversity) and business management (MBA). Multicultural, Swiss citizen, healso wrote and contributed to several scientific papers, articles for the generalpublic, specialized magazines and gave lecturers at several universities acrossall continents.
Dr. Kyriakos Kokkoris - Agnostic Entrepreneur
8 years full time entrepreneur and CEO experiencing first hand the roller coaster of start-ups. Worked and lived in 7 countries in 3 different continents. PhD in Fundamental Microbiology.
Agnostic when it comes to business (involved in projects dealing with genetics, psychology, blockchain and creation of smart contracts with a focus on clinical data/gambling/real estate, cyber security solutions to detect malware attacks from first request, crypto-trading bots, gamification of genetics and psychology, data collection and labelling for AI use, food e-shop and packaging…).
Hands-on experience from idea-to-commercialisation with a focus on go-to-market strategy, product development, sales, fundraising and team building (as co-founder and CEO dealt from licensing to pitching to angel investors and VCs, social media ad campaigns, blog content, B2B and B2C sales...).
Love traveling and exploring new places and cultures, and can't live without my friends & family and since June 2014 I am a proud dad of a baby boy.
Kyriakos at a glance: authentic, pragmatic, trustworthy, extrovert with introvert moments, dreamer, spontaneous, work hard party harder, hate routine, multi-focused, open to new experience, success driven, do not give up easily, confident, decisive, multicultural, multidisciplinary and passionate.
Hanne Langmoen is Senior Business Director International at embecta.
Before joining the MedTech industry almost 5 years ago, she spent close to 20 years in Procter & Gamble across various commercial functions. She has extensive leadership experience across a variety of roles within P&L management, Marketing, Sales and Strategy. She is passionate about identifying growth opportunities for businesses through a customer-centric approach, whether it be as an entrepreneur in the eCommerce space or as an executive in an international, corporate set-up. She has lived & worked in emerging as well as developed markets, and is fluent in 6 European languages.
Areas of expertise: B2B & B2C Commercialization(marketing and sales), Digital Marketing, Customer Understanding, P&L management, eCommerce, Diabetes Industry
She holds a Bachelor Degree from HEC Lausanne, Switzerland.
Nicolas Loeillot is a senior technology entrepreneur and investor.
Back in 2003, he founded a computer vision company in Japan. Pioneering in A.I. applications, his company served hundreds of projects with large companies in Japan, Asia and the US before being acquired by a GAFA in 2017. Since 2010, he chairs the Tokyo Interaction Center, a privately-owned incubator in central Tokyo, focused on early stage deep technologies.
In 2018, Nicolas Loeillot joined the Swiss health insurer Groupe Mutuel as Chief Innovation Officer to set up an innovation strategy, accelerate deployments of A.I. and craft a data-driven, prevention-focused future of the company. In 2021 he joins InnoSuisse as Expert for a 4-year mandate.
Mariam has 15+ years of senior managerial experience in Food & Bev, first at Starbucks and then at Nestle. In these various roles she developed deep expertise in M&A, innovation and strategy.
She is also a judge and mentor for MassChallenge, a lecturer in strategy at the Solvay Business School, and is very actively involved with Ashoka, the leading global network of social entrepreneurs. She started her career as a management consultant at McKinsey and holds an MBA from the Harvard Business School.
Christopher has more than 20 years of experience in the Biopharma / Medtech sector.
He has worked on a number of therapies important to woman’s health such as Fertility treatments, Stress Urinary Incontinence and Chronic Inflammatory Diseases (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis and Crohn Disease).
His domain of expertise covers Strategy, Sales & Marketing, R&D Portfolio Management, Market Access & Pricing, Change Management, Innovation and Digital Transformation. A large part of his recent work has been focusing on product launches, woman’s specific health needs and improvement of Patient Journeys.
Christopher worked for small companies in Europe and the USA as well as larger companies such UCB, Merck Serono, Medtronic and McKinsey. He holds an MBA in Marketing and Finance from the Kellogg Graduate School of Management, Northwestern University (Chicago).
Functions: Strategy, Sales & Marketing, Digital Health, Patient Experience, Finance (business case), Business Development and R&D portfolio (innovation) management
Therapeutic areas: Dermatology, Rheumatology, Neurology, Orthopedic Surgery, Plastic surgery
Indications: Chronic inflammatory diseases such as: Psoriasis, Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Multiple Sclerosis, Lupus Nephritis; as well as Fertility treatments, Incontinence and Severe Osteoporosis
Jerome Michaud is EPFL Engineer (materials science) with about 10 years’ experience on product innovation/supply chain operations. He is able to communicate and engage efficiently across functions/levels and is results oriented, passionate about innovation, people development, and excellent in operations.
Currently he is the Head of Initiative Operations for Health Care which includes the recently acquired Merck portfolio (800 SKUs / 60+ manufacturing sites). His team (15+ people) is responsible for technical and supply chain operations across product & commercial innovation, regulatory/compliance as well as cost saving activities. On top of people management and talent development he has shared responsibility for portfolio management and end to end process optimization.
Industry Expertise: Retail & Consumer Health, more specifically Food Supplements, Cough &Cold, Pain / Relief, Sleep
Disciplines: Business & Supply Chain operations, Innovation & Project Management, Process & Organizational design / transformation, People Management
Cédric Morel is the Managing Director of Sensile Technologies, a forerunner in the Internet of Things (IoT) from the EPFL. He has been managing the company since 2004 and made it one of the world leading IoT provider. In 2020, he successfully closed the sales of the company to the WIKA Group.
He holds a Master in Material Science and Engineering from the EPFL and a MBA from the University of Lausanne. Before joining Sensile Technologies, he worked for 3 years in Japan developing reactors for chemical vapour deposition of diamond.
Cédric’s core competences lay in the international business development, growing companies with limited resources and hiring the right talents. He strongly believes in a good work-life balance allowing the team to succeed on the long run.
He is currently active as a mentor for the EPFL students about to graduate, for start-ups at Innosuisse and for DuoL, an organisation offering help to unemployed seniors to get back in the job market.
Cédric speaks French, English, German and still some Japanese. His passions beside technology are mountaineering and ultra-trail running. Fun fact to finish, he used to play with the Swiss tchoukball team and became World Champion in 2004 and European champion in 2003.
Stasia Obremskey is the Managing Director of RH Capital Funds an impact venture capital fund of Rhia Ventures where she is responsible for investing in innovations in women’s reproductive health. She joined Rhia Ventures at its founding in 2018 after more than twenty-five years of experience as an interim CFO for non-profit organizations and start-up companies and an impact investor and philanthropist in women’s reproductive health.
She holds a bachelor’s degree in Business Administration with a concentration in Finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. She has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions. Stasia is a founding member of The Maverick Collective, an initiative of PSI. As the proud mother of three young adults, she is working with scientists and entrepreneurs to find the next generation of hormone-free contraceptives to meet their sexual health needs.
Samantha is enabling collaborative innovation in the Life Sciences and the Healthcare domains. Working as Head of Research and Business Development for Life Science Technologies at CSEM, she is responsible for identifying market needs and for the strategic planning of internal activities towards specific industrial requests. CSEM plays a key role in the innovation value chain, leveraging public-private partnerships and narrowing the gap between fundamental research and industrialization.
Samantha has a strong interest and passion for personalized medicine and the development of novel technologies for a precise, robust, and accessible healthcare. She earned her Ph. D. Degree from the University of Fribourg and then worked as Post Doc at the Laboratory of Experimental Immunology in Basel. Samantha is a diversity and inclusion advocate promoting gender equity in business and healthcare.
Keywords: diagnostics, biosensors, point of care, digital health, regenerative medicine, automation, µfluidics, organ-on-a-chip, organoids, cell therapy, innovation.
Healthcare executive with over 20 years’ experience. Ksenija is currently the CEO of ex-Sofinnova portfolio company PregLem SA, a reproductive health pharma company based in Geneva. She also works as an operational investor at JEITO Investment fund. She joined PregLem at inception late 2007 as one of the early members of the team, initially led business development and marketing and then became CCO and CEO. During her tenure, she led the negotiations of several licensing deals which expanded PregLem’s portfolio and was instrumental in developing cumulative sales of over €260mn within five years of drug launch. Ksenija also led, for PregLem, the negotiations for the company’s sale to Gedeon Richer for CHF445 mn(€337mn).
Prior to PregLem, Ksenija worked for seven years with Serono (then Merck Serono) in sales and marketing.
Ksenija has frequently acted as operational advisor to venture capital, including Sofinnova Partners.
Cindy is currently the Global Brand Director for Disruptive Innovation & Sustainability at Procter & Gamble for Oral Care Business Unit. She is a business & marketing manager with 11+ years of international experience in Oral Health Care and has led projects across Europe, the United States, Latin America, India, Middle East, and Africa.
In her current role, she leads upstream innovation teams to define the business model, product architecture, product/services portfolio, product and experiences that create value for the brand, consumers and customers. She is an expert practitioner of Design Thinking, Lean Innovation methodologies, as well as Brand Strategy & Consumer Understanding.
She is an effective communicator and translator of business needs and technical concepts across the organization and business ecosystem, given her experience at different organizational levels of Procter & Gamble and her technical background as an Industrial Engineer.
Industry Expertise: FMCG, Retail & Consumer Health
- Lean/Disruptive Innovation, Business Model Innovation, Market/Opportunity Identification, Design Thinking,
- Brand Building, Strategy & Planning, Brand Equity Development, Product, Packaging & Identity Design, Digital Marketing & Media, Brand Monetization, Agency +Trade Relations, Project Management,
- Human & Behavioral Science Application, Consumer Understanding & Insights.
- Business Sustainability Management, Sustainability Strategy
Bio Marco Rüedi, MD, eMBA, eMMM
Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management.
He is a strong believer in well-balanced teams: motivated to challenge the status quo!
Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.
He holds a Medical Doctor from the University of Fribourg, Berne and Zurich, an Executive Masters in Medical Management from eMMM PHW Bern, and an Executive Masters in Business Administration from eMBA PHW Bern.
Kai currently is Director Essity Ventures at the leading global health and hygiene company Essity, being home to many global brands in sectors such as feminine care, consumer tissue, and medical solutions.
Essity Ventures is Essity’s venturing and business model innovation vehicle.
Along his +15 year career path, Kai has taken on senior management positions at major CPG companies like Essity, Mondelez, Kraft Foods, and Reckitt Benckiser.
He has worked in e.g. Corporate Venturing, Consumer Marketing, Brand Management, Innovation, Digital Marketing & Media, eCRM, eCommerce (DtC, Pure Play, Bricks & Clicks), Key Account Sales, Field Sales, Employer Branding, Brand Monetization.
Kai has built and developed corporate venturing and business model innovation units in corporates.
Besides that, he led/implemented consulting projects for corporates in the domain of business model innovation as well as business unit design and creation.
Areas of Functional Expertise: Marketing, Brand Building, Digital Marketing & Media, eCRM, eCommerce (D2C, Amazon, Bricks & Clicks), Sales Key Account, Sales Field Force Retail, HR/Employer Branding, Brand Monetization, Digital Retail & Performance Media
Areas of “Methodological” Expertise: Business Model Innovation, Corporate Innovation, Innovation & Media Consulting, Venturing, Team/Unit Building, Agency +Trade Relations
Martin Velasco is an entrepreneur and Business Angel with extensive experience in the IT, medical and biotech areas.
He is the Founder, Chairman and CEO of Anecova, an assisted reproductive technology (ART) company and World Economic Forum Technology Pioneer 2008. He serves on the board/advisory board of several high-tech companies including: AC-Immune, a leader in Alzheimer's and neurodegenerative diseases drug development and World Economic Forum Technology Pioneer 2009, as Vice Chairman; Aridhia, a Health Informatics company, as Board Member and Cocomore, a digital communications agency & IT services firm, as Chairman of the Supervisory Board. Martin is also the Founder of Infantia Foundation, a philanthropic organisation aiding children in the developing world. He is Member of the Fondation EPFL Innovation Park and member of the Strategic Advisory Board at the Ecole Polytechnique Fédérale de Lausanne (EPFL).
Alice Zheng has been a women’s health enthusiast throughout her career spanning global health, clinical medicine, and the private sector. She currently a Principal at Rhia Ventures, a women's health-focused impact fund, leading investments in innovative women's health companies. Alice was previously a women’s health practice leader and management consultant at McKinsey & Company, where she served biopharma, diagnostics, global public health and private equity clients across R&D and commercial strategy topics.
Earlier in her career, Alice’s passion to improve lives for the underserved led her to work in East Africa and Asia in reproductive health and family planning with EngenderHealth, Marie Stopes International and other nonprofits. As a clinician, she focused on women’s health globally and published articles examining healthcare in low-income countries.
Alice holds an MBA from Harvard Business School and MD and MPH from the University of Michigan, where she was a Dean's Merit Scholar. Alice is a frequent speaker on FemTech and women's health innovation and is a steering committee member for multiple women’s health innovation forums.
Lan is the Deputy Managing Director of EPFL Innovation Park and an Expert of Innosuisse – the Swiss Innovation Agency. She has 23years of hands-on professional experience in industry as well as in the ecosystem of innovation & entrepreneurship.
Lan started her career at R&D department of Rolex, in charge of creating new computer aided design and optimisation tools in the product development process. She was later appointed as Head of Operational Planning at Pictet, working closely with a startup to design, develop and implement a management information system for group operation control. As the Managing Director of Geneva Creativity Center, she connected large corporations, SMEs, startups and researchers to initiate innovative joint R&D projects.
Currently at EPFL Innovation Park, she is leading entrepreneurship training and acceleration programs and is helping startups to establish business partnership with large corporations. Lan has a PhD degree from EPFL, an MBA from HEC Lausanne and postdoctoral applied research experience at Stanford University.
Jean spent over 20 years in technology oriented companies. His domains of expertise range from international sales to management of IT telecom businesses and company organisation. While an executive in large multinational companies, he experienced many of the domestic and international development stages of a corporation. Jean is also an entrepreneur and started several ventures which have been successfully sold. Jean is currently a chairman or board member of several small and medium-sized companies and start-ups. He also acts as a lecturer for institutions like UNIL, RCE, Board Academy and ZHAW and advises entrepreneurs and SMEs for Innosuisse and Innovaud.
Raymon uit de Bulten is an experienced and results-driven leader in new proposition and business creation at Philips. As Director Start-up Ventures he leads a team of cross-functional intrapreneurs in developing new solutions and business models via internal ventures and incubators. Outward looking, creative and forward-thinking; Raymon specializes in bringing together business opportunities, innovation and design to create meaningful consumer solutions.
“We’re here to put a dent in the universe. Otherwise, why even be here?” Steve Jobs tweeted that in 1985 (well he said it in an interview, these were the 80’s). Meet Jeroen van den Oever, leading finance and operations at SUN bioscience, the Organoid company. Straight talking Dutch financial expert trying to make a remarkable difference in the world around us. Equipped with a wicked sense of humour and a hunger to challenge the status quo he is out to improve drug development through innovation and entrepreneurship.
Founder of a regulatory technology start-up (sold in 2010) he converted an early technology project into a viable business with clients in the corporate world. Wanting to pay forward what he had learnt Jeroen started sharing his experience with start-ups and corporates alike. Jeroen’s talent was spotted at SUN bioscience that offered him the opportunity to join the company and never be bored again.
Jeroen is a licensed CPA and experienced board member. He learnt the trade in the first 12 years of his career at KPMG. For inquiries reach out to him on LinkedIn.
Tanja Dowe is the CEO of Debiopharm Innovation Fund, the digital health investment arm of Debiopharm located in Lausanne, Switzerland. Passionate about transforming healthcare and pharmaceutical development through digital innovation, Tanja is constantly on the look for ambitious entrepreneurs who do not settle for status quo. During her 20 year career as an entrepreneur and international transaction & strategy consultant at Innomedica before joining Debiopharm, she worked with more than 80 medical & healthcare companies globally, giving her a broad view into product development, team building and commercial strategies that work - and some that don't. Tanja is an experienced board member and chairwoman with a track record of successful M&A exits. MSc Tech in Applied Microbiology and Biochemistry from Helsinki University of Technology.
Forward-thinking high performing business development professional who consistently outperforms expectations.
Successful track record in sourcing business development opportunities, deal negotiations, and closures from discovery to development stage opportunities, including academic partnerships and collaborations.
Recognized as a biopharmaceutical business development professional experienced with a diverse portfolio of transactions including discovery/research collaborations, co-development/co-promote arrangements, licensing (in/out), M&A, divestitures/spin-outs, option deals, and asset deals (buy/sell).
Proficient in communicating and engaging with C-level executives to accomplish goals and objectives. Skilled in spearheading strategic change management processes/initiatives in the company (both in R&D, commercial operation, and overall company direction).
Pascal started his professional career at McKinsey, after studies at the University of St. Gallen and Columbia Business School. Over the last 20 years he built three startups in the healthcare space – the latest being Ava. And successfully raised ten financing rounds – from USD 100k to USD 30m – with investors from all over the world. Pascal currently lives in Zurich, and spends substantial time in San Francisco, Shenzhen and other tech centers around the world.